Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea · Delayed Price · Currency is KRW

2,365.00

+130.00 (5.82%)

At close: Jul 31, 2026

Korea Arlico Pharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	199,144	201,204	190,436	187,155	167,737	140,157
Revenue Growth	1.36%	5.65%	1.75%	11.58%	19.68%	12.30%
Gross Profit	103,980	104,230	99,728	110,116	106,866	87,485
Operating Income	-1,781	989.24	-5,159	3,073	9,864	4,794
Net Income	-1,625	-605.35	-5,358	3,061	8,034	4,930
Earnings Per Share	-107.81	-40.32	-357.00	104.00	532.00	327.00
EPS Growth	-	-	-	-80.45%	62.69%	-41.08%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	21,045	20,993	19,194	30,790	32,203	28,747
Total Debt	44,807	49,044	50,457	46,289	31,096	12,601
Net Cash (Debt)	-23,762	-28,051	-31,263	-15,499	1,107	16,146
Net Cash Growth	-	-	-	-	-93.14%	64.53%
Net Cash Per Share	-1576.54	-1868.42	-2082.99	-526.62	73.29	1071.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	14,693	9,995	-8,583	7,148	4,836	8,967
Capital Expenditures	-2,449	-3,112	-3,501	-23,385	-18,974	-5,268
Free Cash Flow	12,244	6,883	-12,085	-16,237	-14,137	3,699
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	52.21%	51.80%	52.37%	58.84%	63.71%	62.42%
Operating Margin	-0.89%	0.49%	-2.71%	1.64%	5.88%	3.42%
Pretax Margin	-1.18%	-0.54%	-3.24%	1.86%	5.00%	4.00%
Profit Margin	-0.82%	-0.30%	-2.81%	1.64%	4.79%	3.52%
FCF Margin	6.15%	3.42%	-6.35%	-8.68%	-8.43%	2.64%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	28.54	12.50	23.88
P/FCF Ratio	2.96	9.52	-	-	-	31.82
PS Ratio	0.18	0.33	0.28	0.47	0.60	0.84